Maxicon Pharmaceuticals Private Limited
Pharmaceutical company specializing in manufacturing, importing, and exporting medicines and healthcare products.
2015 | Delhi (India) | Active
Maxicon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth 36.35%
- Total Assets 16.79%
About Maxicon Pharmaceuticals
Maxicon Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 May 2015 (Nine years and nine months 14 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Saini, Sapna Saini, and Abhishek Sharma serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100DL2015PTC280621
- Company No.
280621
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
What products or services does Maxicon Pharmaceuticals Private Limited offer?
Maxicon Pharmaceuticals Private Limited offers a wide range of products and services, including Paracetamol Tablets, Crocin Advance Tablet, Crocin Tablets.
Who are the key members and board of directors at Maxicon Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Sharma  | Director | 27-Oct-2016 | Current |
| Suresh Saini | Director | 22-May-2015 | Current |
| Sapna Saini | Director | 22-May-2015 | Current |
Financial Performance of Maxicon Pharmaceuticals.
Maxicon Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 36.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Maxicon Pharmaceuticals?
In 2018, Maxicon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Maxicon Pharmaceuticals?
Unlock and access historical data on people associated with Maxicon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maxicon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxicon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Maxicon Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Maxicon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Maxicon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Director Appointment
Abhishek Sharma was appointed as a Director was appointed as a Director on 27 Oct 2016 & has been associated with this company since 8 years 4 months .
- Director Appointment
Suresh Chand Saini was appointed as a Director was appointed as a Director on 22 May 2015 & has been associated with this company since 9 years 9 months .
- Director Appointment
Sapna Saini was appointed as a Director was appointed as a Director on 22 May 2015 & has been associated with this company since 9 years 9 months .
- Company Incorporation
Maxicon Pharmaceuticals Private Limited was registered on 22 May 2015 with Roc Delhi & aged 9 years 9 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Maxicon Pharmaceuticals Private Limited?
Maxicon Pharmaceuticals Private Limited was incorporated on 22 May 2015.
What is authorized share capital and paid-up capital of Maxicon Pharmaceuticals Private Limited?
The authorized share capital of Maxicon Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Maxicon Pharmaceuticals Private Limited?
Currently 3 directors are associated with Maxicon Pharmaceuticals Private Limited.
- Suresh Chand Saini
- Sapna Saini
- Abhishek Sharma
What is the registered address of Maxicon Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Maxicon Pharmaceuticals Private Limited is X-3137 Gali No. 4, Raghubar Pura Ii Gandhi Nagar India, Delhi, 110031.
What is the corporate identification number (CIN) and company number of Maxicon Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Maxicon Pharmaceuticals Private Limited is U24100DL2015PTC280621 and the company number is 280621 as per Ministry of Corporate Affairs (MCA).
What change has been observed in the net worth of Maxicon Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Maxicon Pharmaceuticals Private Limited has experienced an upsurge of 36.35%.
When was the last Balance Sheet of Maxicon Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Maxicon Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.